Recent Financing
Recent Raise
Anagram Therapeutics is a clinical-stage biopharmaceutical company developing orally delivered enzyme therapeutics for malabsorption syndromes and nutrient metabolism disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor
See the team members at Anagram Therapeutics.
